SofWave Medical Ltd. (TLV:SOFW)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
3,661.00
-16.00 (-0.44%)
At close: Jan 14, 2026
125.85%
Market Cap1.31B
Revenue (ttm)255.13M
Net Income (ttm)2.26M
Shares Out35.69M
EPS (ttm)0.06
PE Ratio579.38
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume27,158
Average Volume59,534
Open3,800.00
Previous Close3,677.00
Day's Range3,602.00 - 3,800.00
52-Week Range1,300.00 - 3,800.00
Beta0.70
RSI77.59
Earnings DateMar 4, 2026

About SofWave Medical

SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin rejuvenation and firming treatments in Israel and internationally. The company offers an ultrasound technology, which induces coagulation and subsequent revitalization under the SUPERB brand name; and non-invasive muscle toning technology under the Pure Impact brand. It serves plastic surgeons, dermatologists, and other physicians who perform aesthetic treatments on patients. The company was incorporated in 2015 a... [Read more]

Sector Healthcare
Founded 2015
Employees 126
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol SOFW
Full Company Profile

Financial Performance

In 2024, SofWave Medical's revenue was $59.65 million, an increase of 18.56% compared to the previous year's $50.32 million. Losses were -$4.55 million, -45.08% less than in 2023.

Financial numbers in USD Financial Statements

News

There is no news available yet.